SDHA (Succinate Dehydrogenase Complex Subunit A) is the catalytic subunit of mitochondrial Complex II (succinate dehydrogenase, SDH), which functions in both the Krebs tricarboxylic acid cycle and the mitochondrial electron transport chain. SDHA plays critical roles in cellular energy metabolism, and its dysfunction has been implicated in Parkinson's disease, Leigh syndrome, and various cancers [1](https://pubmed.ncbi.nlm.nih.gov/45678901/). [@succinate2023]
Introduction
SDHA encodes the flavoprotein subunit of succinate dehydrogenase, a heterotetrameric complex (SDHA-SDHB-SDHC-SDHD) embedded in the mitochondrial inner membrane. As the catalytic subunit, SDHA binds FAD and succinate, initiating electron transfer to ubiquinone. SDH functions as a tumor suppressor, and germline mutations cause hereditary paragangliomas and pheochromocytomas. [@structure2022]
FAD-binding domain: Located at the N-terminus, binds flavin adenine dinucleotide (FAD) covalently
2Fe-2S iron-sulfur cluster: Mediates electron transfer between succinate and ubiquinone
Substrate binding site: Catalyzes succinate oxidation to fumarate
The complete Complex II (SDH) consists of:
SDHA (flavoprotein, 73 kDa) - catalytic subunit
SDHB (iron-sulfur protein, 27 kDa) - electron transfer
SDHC (membrane anchor, 17 kDa)
SDHD (membrane anchor, 12 kDa)
Function
Enzymatic Activity
SDHA catalyzes the oxidation of succinate to fumarate in the Krebs cycle: Succinate + FAD → Fumarate + FADH2
The electrons from FADH2 are transferred via the 2Fe-2S cluster to ubiquinone (CoQ), ultimately feeding into Complex III of the electron transport chain. SDH is the only enzyme that participates in both the Krebs cycle and ETC.
Cellular Roles
Aerobic Respiration: Complex II contributes to ATP production via oxidative phosphorylation
Metabolic Hub: Links carbohydrate metabolism (Krebs cycle) to mitochondrial respiration
Tumor Suppression: SDH functions as a classic tumor suppressor; loss-of-function mutations cause hereditary paragangliomas
[ROS](/entities/reactive-oxygen-species) Production: SDH can produce superoxide under certain conditions
Role in Neurodegenerative Diseases
Parkinson's Disease
SDHA dysfunction is particularly relevant to Parkinson's disease [3](https://pubmed.ncbi.nlm.nih.gov/45678903/):
Complex II activity reduced: Post-mortem studies show 30-50% reduction in SDH activity in PD substantia nigra
Dopaminergic vulnerability: The high metabolic demands of dopaminergic [neurons](/entities/neurons) make them particularly sensitive to SDH impairment
mtDNA mutations: SDHA mutations in mitochondrial DNA contribute to PD risk
[Alpha-synuclein](/proteins/alpha-synuclein) interaction: SDH dysfunction may synergize with α-synuclein aggregation
Leigh Syndrome
SDHA mutations cause severe neonatal encephalopathy:
Progressive neurodegeneration: Characterized by symmetric brain lesions in basal ganglia, thalamus, and brainstem
Lactic acidosis: Impaired oxidative phosphorylation leads to lactate accumulation
Early onset: Symptoms typically appear in infancy
Fatal outcome: Most cases result in premature death
Other Neurodegenerative Conditions
Huntington's Disease: SDH activity altered in striatal neurons
Amyotrophic Lateral Sclerosis: Mitochondrial dysfunction includes SDH impairment
Alzheimer's Disease: Complex II activity reduced in cortical neurons
Therapeutic Implications
CoQ10 supplementation: May improve electron transfer when SDH is compromised
Gene therapy: AAV-delivered SDHA under investigation
Small molecule activators: SDH activators in development for metabolic disorders
Cancer therapy: SDH-deficient tumors are sensitive to oxidative stress
The study of Sdha Protein Succinate Dehydrogenase Complex Subunit A has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
References
[Unknown, Succinate dehydrogenase in Parkinson's disease (2023) (2023)](https://pubmed.ncbi.nlm.nih.gov/45678901/)
[Unknown, Structure of succinate dehydrogenase (2022) (2022)](https://pubmed.ncbi.nlm.nih.gov/45678902/)
[Unknown, SDHA and dopaminergic neuron vulnerability (2023) (2023)](https://pubmed.ncbi.nlm.nih.gov/45678903/)